Research Article

Robot-Assisted versus Laparoscopic-Assisted Gastrectomy among Gastric Cancer Patients: A Retrospective Short-Term Analysis from a Single Institution in China

Table 2

Comparison of two subgroups according to the learning curve of the RAG group.

Clinicopathological featuresFH () valueSH () value

Gender (male/female)17/35/30.31148/2019/60.606
Age (years)0.8700.715
ASA (2/3)15/56/21.00058/1024/10.291
BMI (kg/m2)0.6730.897
Comorbidity2 (10.00%)1 (12.50%)1.00019 (27.94%)6 (24.00%)0.704
Resection type (total/distal)5/153/50.65120/484/210.190
Reconstruction type (B-I/B-II/R-Y)5/10/52/3/30.86514/34/208/12/50.444
Tumor location (U/M/L)3/2/153/2/30.14213/13/424/3/180.744
Operation time (min)0.0140.006
Estimated blood loss (ml)0.7840.003
Tumor size (cm)0.1470.121
T stage1.0000.065
 T1a4 (20.00%)2 (25.00%)14 (20.59%)11 (44.00%)
 T1b3 (15.00%)1 (12.50%)16 (23.53%)4 (16.00%)
 T27 (35.00%)3 (37.50%)13 (19.12%)7 (28.00%)
 T35 (25.00%)2 (25.00%)18 (26.47%)3 (12.00%)
 T4a1 (5.00%)0 (0.00%)7 (10.29%)0 (0.00%)
N stage0.6850.550
 N011 (55.00%)5 (62.50%)36 (52.94%)18 (72.00%)
 N13 (15.00%)2 (25.00%)14 (20.59%)2 (8.00%)
 N24 (20.00%)0 (0.00%)10 (14.71%)3 (12.00%)
 N3a2 (10.00%)1 (12.50%)7 (10.29%)2 (8.00%)
 N3b0 (0.00%)0 (0.00%)1 (1.47%)0 (0.00%)
TNM stage0.9510.270
 Ia6 (30.00%)3 (37.50%)24 (35.29%)13 (52.00%)
 Ib3 (15.00%)2 (25.00%)10 (14.71%)4 (16.00%)
 IIa5 (25.00%)1 (12.50%)12 (17.65%)3 (12.00%)
 IIb2 (10.00%)1 (12.50%)5 (7.35%)4 (16.00%)
 IIIa2 (10.00%)0 (0.00%)9 (13.24%)0 (0.00%)
 IIIb2 (10.00%)1 (12.50%)5 (7.35%)1 (4.00%)
 IIIc0 (0.00%)0 (0.00%)3 (4.41%)0 (0.00%)
Number of harvested LNs0.4440.008
Number of harvested No. 9 LNs0.6630.045
Number of harvested suprapancreatic LNs0.372
Days of the first passing flatus (days)0.3950.092
Hospital stay after surgery (days)0.6560.728
Postoperative complications4 (20.00%)4 (50.00%)0.1728 (11.76%)2 (8.00%)0.887
30-day readmission after surgery0 (0.00%)0 (0.00%)1.0002 (2.94%)1 (4.00%)1.000

, statistical significance.